Matches in SemOpenAlex for { <https://semopenalex.org/work/W3025164711> ?p ?o ?g. }
- W3025164711 endingPage "2356" @default.
- W3025164711 startingPage "2349" @default.
- W3025164711 abstract "The introduction of biologics for the treatment of patients with refractory asthma represented a marked therapeutic advance. For more than 10 y, the only biologic available has been the monoclonal anti-IgE antibody omalizumab, reserved for patients with asthma caused by perennial allergen. In recent years, other biologics have been licensed for the treatment of severe eosinophilic asthma. They include monoclonal antibodies that target the Th2-pathway cytokines, such as IL-5 (mepolizumab and reslizumab) or its receptor (benralizumab) and the IL-4 and IL-13 receptor (dupilumab). The effectiveness of these biologics was demonstrated in several placebo controlled trials, the main outcomes being the significant reduction of the rate of asthma exacerbation and the improvement of respiratory function in actively treated patients. Based on the further understanding of the pathogenesis of asthma, new cytokines network and new targets are emerging, such as thymic stromal lymphopoietin, which can activate Th2 cells, innate lymphoid cells, or both, or prostaglandin D2 (PGD2), to develop additional biologics." @default.
- W3025164711 created "2020-05-21" @default.
- W3025164711 creator A5009038084 @default.
- W3025164711 creator A5026144628 @default.
- W3025164711 creator A5035925941 @default.
- W3025164711 creator A5047831572 @default.
- W3025164711 creator A5076022784 @default.
- W3025164711 creator A5079142638 @default.
- W3025164711 creator A5089900009 @default.
- W3025164711 date "2020-05-13" @default.
- W3025164711 modified "2023-10-16" @default.
- W3025164711 title "Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab" @default.
- W3025164711 cites W150589858 @default.
- W3025164711 cites W1885649436 @default.
- W3025164711 cites W1916962812 @default.
- W3025164711 cites W1988758075 @default.
- W3025164711 cites W1994722540 @default.
- W3025164711 cites W2006698613 @default.
- W3025164711 cites W2021701428 @default.
- W3025164711 cites W2026119244 @default.
- W3025164711 cites W2036075099 @default.
- W3025164711 cites W2039252747 @default.
- W3025164711 cites W2039930386 @default.
- W3025164711 cites W2046313062 @default.
- W3025164711 cites W2050237494 @default.
- W3025164711 cites W2061775758 @default.
- W3025164711 cites W2066962548 @default.
- W3025164711 cites W2074113024 @default.
- W3025164711 cites W2075699130 @default.
- W3025164711 cites W2095754126 @default.
- W3025164711 cites W2100705331 @default.
- W3025164711 cites W2108344016 @default.
- W3025164711 cites W2110052844 @default.
- W3025164711 cites W2120018683 @default.
- W3025164711 cites W2124566107 @default.
- W3025164711 cites W2138355864 @default.
- W3025164711 cites W2140957405 @default.
- W3025164711 cites W2142587628 @default.
- W3025164711 cites W2149336558 @default.
- W3025164711 cites W2149809437 @default.
- W3025164711 cites W2153642908 @default.
- W3025164711 cites W2159262373 @default.
- W3025164711 cites W2165277651 @default.
- W3025164711 cites W2167829087 @default.
- W3025164711 cites W2167854532 @default.
- W3025164711 cites W2176211632 @default.
- W3025164711 cites W2309688181 @default.
- W3025164711 cites W2338443462 @default.
- W3025164711 cites W2342693354 @default.
- W3025164711 cites W2370552689 @default.
- W3025164711 cites W2489023657 @default.
- W3025164711 cites W2511120040 @default.
- W3025164711 cites W2513258422 @default.
- W3025164711 cites W2515998798 @default.
- W3025164711 cites W2533837888 @default.
- W3025164711 cites W2619633721 @default.
- W3025164711 cites W2726269469 @default.
- W3025164711 cites W2761905894 @default.
- W3025164711 cites W2803404900 @default.
- W3025164711 cites W2883146779 @default.
- W3025164711 cites W2894400044 @default.
- W3025164711 cites W2899608945 @default.
- W3025164711 cites W2908121480 @default.
- W3025164711 cites W2947699537 @default.
- W3025164711 cites W2969921507 @default.
- W3025164711 cites W4254446533 @default.
- W3025164711 doi "https://doi.org/10.1080/21645515.2020.1753440" @default.
- W3025164711 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7644228" @default.
- W3025164711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32401603" @default.
- W3025164711 hasPublicationYear "2020" @default.
- W3025164711 type Work @default.
- W3025164711 sameAs 3025164711 @default.
- W3025164711 citedByCount "13" @default.
- W3025164711 countsByYear W30251647112020 @default.
- W3025164711 countsByYear W30251647112021 @default.
- W3025164711 countsByYear W30251647112022 @default.
- W3025164711 countsByYear W30251647112023 @default.
- W3025164711 crossrefType "journal-article" @default.
- W3025164711 hasAuthorship W3025164711A5009038084 @default.
- W3025164711 hasAuthorship W3025164711A5026144628 @default.
- W3025164711 hasAuthorship W3025164711A5035925941 @default.
- W3025164711 hasAuthorship W3025164711A5047831572 @default.
- W3025164711 hasAuthorship W3025164711A5076022784 @default.
- W3025164711 hasAuthorship W3025164711A5079142638 @default.
- W3025164711 hasAuthorship W3025164711A5089900009 @default.
- W3025164711 hasBestOaLocation W30251647111 @default.
- W3025164711 hasConcept C141105273 @default.
- W3025164711 hasConcept C159654299 @default.
- W3025164711 hasConcept C203014093 @default.
- W3025164711 hasConcept C2776042228 @default.
- W3025164711 hasConcept C2777037409 @default.
- W3025164711 hasConcept C2777832160 @default.
- W3025164711 hasConcept C2778070265 @default.
- W3025164711 hasConcept C2778564945 @default.
- W3025164711 hasConcept C2779185760 @default.
- W3025164711 hasConcept C2779824493 @default.
- W3025164711 hasConcept C71924100 @default.
- W3025164711 hasConceptScore W3025164711C141105273 @default.